The Market Is Rolling Over… These 2 Stocks REFUSE to Break
4 extracted signals · 1 resolved · 3 still active
Ross GivensIndependent analyst profile- Source published
- 29 Sept 2026, 19:36 UTC
- Recorded by Tahlil Plus
- 29 Sept 2026, 20:41 UTC
AI-generated source summary
The analysis focuses on two individual stocks, MU and SNDK, and two ETFs, QQQ and RSP. MU is currently trading around $1071.50 and is predicted to reach $1300.00 with a stop-loss at $948.00, indicating a bullish outlook. SNDK is trading at $1710.00 with a target of $2200.00 and a fail bound of $1400.00, also suggesting a bullish trend. QQQ is near its high at $733.61, with a neutral to slightly bullish outlook, targeting $750.00 and invalidating below $720.00, indicating a potential range-bound movement. RSP, however, is showing a bearish trend, trading at $212.49, with a target of $230.00 but a fail bound at $205.00, implying a potential bearish move. The broader market sentiment appears mixed, with the Nasdaq Composite Index showing weakness as the percentage of stocks above their 200-day moving average has fallen significantly, suggesting a potential downside risk despite individual stock strength.
AI-generated summary based on the source content.
Signal outcomes at a glance
Partially ResolvedSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
4 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Live evaluation in progress
3 signals remain active.
Ross Givens
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.